IRCT20161207031288N6RecruitingPhase 2
consideration of clinical safety and efficacy of topical formulation of polyphenolic extract of punica granatum on patients with mild to moderate forms of melasma
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •Mild to moderate melasma with minimum grade of Melasma area and severity index = 1
- •Age range 18-50
- •Signing consent form, voluntarily and knowingly
Exclusion Criteria
- •Pregnancy or lactation
- •Using oral corticosteroids or isotretinoin within 28 days prior to the study
- •Any active skin disease at test area including rosacea, eczema, atrophy, acne
- •Using any light sensitizing medicine within 3 months prior to the study
- •Use of topical lightening products like alpha hydroxy acid, beta hydroxy acid, and retinoid component within 21 days prior to the study
- •Documented allergy to components of the cream
- •History of laser treatment or dermabrasion or deep facial peeling within the past 3 months prior to the study
- •Using contraceptive or hormonal medicines
Investigators
Similar Trials
Recruiting
Phase 4
COMPARISON OF THREE DIFFERENT DOSES OF FENTANYL TO PREVENT HEMODYNAMIC STRESS RESPONSE DURING INTUBATIOCTRI/2016/01/006519GOVERNMENT MEDICAL COLLEGE90
Completed
Not Applicable
Clinical Evaluation of Safety and Performance of the BackBeat Moderato System1000752110057166HypertensionNL-OMON40595BackBeat Medical, Inc.10
Not yet recruiting
Phase 3
Effect of tranexamic acid and aprotinin in absolute blood loss in pediatric neurosurgeryIRCT20200705048023N1Tehran University of Medical Sciences90
Completed
Not Applicable
The evaluation of the efficacy and the safety of TSUMURA Tokishakuyakusan Extract Granules for Ethical Use on endometriosis patients with dysmenorrheaEndometriosisJPRN-UMIN000017908Tottori University Faculty of Medicine15
Active, not recruiting
Phase 4
Safety and effectiveness clinical evaluation of the range of injectable hyaluronic acid medical devices in facial aesthetic treatmentModerate to severe peri-oral lines, moderate to severe nasolabial folds, moderate to severe cheeks/cheekbones volume deficit, chin recursionSkin and Connective Tissue DiseasesISRCTN49836437Kylane Laboratoires SA68